Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 11, 1996, Pages 854-860

  Velegraki, A ^a   Papalambrou, D ^a   Soremi, S ^a   Legakis, N J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DRUG SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PHENOTYPE; PRIORITY JOURNAL;

EID: 0029775267     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691215     Document Type: Article

References (25)

1. Ramsey H, Marrow B, Soll DR: An increase in switching frequency correlates with an increase in recombination of the ribosomal chromosomes of Candida albicans strain 3153A. Microbiology 1994, 140: 1525-1531.
2. Slutsky B, Buffo J, Soll DR: High frequency switching of colony morphology in Candida albicans. Science 1985, 230: 666-669.
3. Soll DR: High frequency switching in Candida albicans. Clinical Microbiology Reviews 1992, 5: 183-203.
4. Soll DR, Marrow B, Srikatha T: High frequency switching in Candida albicans. Trends in Genetics 1993: 61-65.
5. Rustchenco-Bulgag EP: Variations of Candida albicans electrophoretic karyotypes. Journal of Bacteriology 1991, 173: 6586-6596.
6. Velegraki A: In vitro susceptibility to itraconazole and fluconazole of switch phenotypes of Candida albicans serotypes A and B, isolated from immunocompromised hosts. Journal of Medical and Veterinary Mycology 1995, 33: 83-85.
7. Kennedy MJ, Rogers AL, Hanselman LR, Soll DR: Variation on adhesion and cell surface hydrophobicity in Candida albicans white opaque phenotypes. Mycopathologia 1988, 12: 149-156.
8. Rustchenco-Bulgac EP, Sherman F, Hicks JB: Chromosomal rearrangements associated with morphological mutants provide a means for genetic variation in Candida albicans. Journal of Bacteriology 1990, 172: 1276-1283.
9. Suzuki T, Kobayashi I, Kanbe T, Tanaka K: High frequency variation in colony morphology and chromosome reorganization in the pathogenic yeast Candida albicans. Journal of Genetics and Microbiology 1989, 135: 225-434.
10. Barton RC, van Belkum A, Scherer S: Stability of karyotype in serial isolates of Candida albicans from neutropenic patients. Journal of Clinical Microbiology 1995, 33: 794-796.
11. Van Belkum A, Melchers W, de Pauw BE, Scherer S, Quint W, Meis JF: Genotypic characterization of sequential Candida albicans isolates from fluconazole treated neutropenic patients. Journal of Infectious Diseases 1994, 169: 1062-1070.
12. Essery SD, Weir DM, Blackwell CC, Saadi AT, Busuttil A, Tzanakaki G: Detection of microbial surface antigens that bind Lewis antigen. FEMS Immunology and Medical Microbiology 1994, 9: 15-22.
13. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-P. NCCLS, Villanova, PA, 1992.
14. Van Rij KNJW: The yeasts. A taxonomic study. Elsevier, Amsterdam, 1984, p. 609-884.
15. Anderson JM, Soll DR: Unique phenotype of opaque cells in the white opaque transition of Candida albicans. Journal of Bacteriology 1987, 169: 5579-5588.
16. Lee KL, Buckley HR, Cambell CC: An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 1975, 13: 148-153.
17. Slutsky B, Stabell M, Anderson J, Risen L, Pfaller M, Soll DR: White-opaque transition: high-frequency switching system in Candida albicans. Journal of Bacteriology 1987, 169: 189-197.
18. Leu HS, Huang CT: Clearance of fungiuria with short-course antifungal regimens: a prospective, randomized controlled study. Clinical Infectious Diseases 1995, 20: 1152-1157.
19. Dutton S, Penn CW: Biological attributes of colony-type variants of Candida albicans. Journal of General Microbiology 1989, 135: 3363-3372.
20. Bedell GW, Soll DR: Effects of low concentrations of zinc on the growth and dimorphism of Candida albicans: evidence for zinc-resistant and sensitive pathways for mycelium formation. Infection and Immunity 1979, 26: 348-354.
21. Jones S, White G, Hunter PR: Increased phenotypic switching in strains of Candida albicans associated with invasive infections. Journal of Clinical Microbiology 1994, 32: 2869-2870.
22. Pfaller MA, Rhine-Chalberg J, Redding SW, Smith J, Farinacci G, Fothergill AW, Rinaldi MG: Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. Journal of Clinical Microbiology 1994, 32: 59-64.
23. Pomes R, Gill C, Nombela C: Genetic analysis of Candida albicans morphological mutants. Journal of General Microbiology 1985, 131: 2107-2113.
24. Datta A, Jinks-Robertson S: Association of increased spontaneous mutation rates with high levels of transcription in yeast. Science 1995, 268: 1616-1618.
25. Agabian N, Odds FC, Poulain D, Soll DR, White TC: Pathogenesis of invasive candidiasis. Journal of Medical and Veterinary Mycology 1994, 32, Supplement 1: 229-237.